CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −100 | $276.40 | $28K | 2,061 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −361 | $277.77 | $100K | 1,700 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −1,100 | $279.46 | $307K | 600 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −200 | $280.41 | $56K | 400 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −200 | $281.79 | $56K | 200 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −200 | $283.61 | $57K | 0 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Option exercise · Stock Option (Right to Buy) | −7,000 | 25,000 | ||
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Option exercise | +30,000 | $60.26 | $1.8M | 30,000 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −593 | $266.04 | $158K | 29,407 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −1,107 | $267.47 | $296K | 28,300 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −1,913 | $268.50 | $514K | 26,387 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −1,476 | $269.61 | $398K | 24,911 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −2,069 | $270.56 | $560K | 22,842 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −2,084 | $271.54 | $566K | 20,758 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −5,534 | $272.68 | $1.5M | 15,224 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −2,471 | $273.54 | $676K | 12,753 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −3,019 | $274.56 | $829K | 9,734 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −811 | $275.70 | $224K | 8,923 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −700 | $276.67 | $194K | 8,223 |
| 2022-12-23 | Sukhija Remy Chief Commercial Officer | Sale | −700 | $277.83 | $194K | 7,523 |
Page 50 of 82 · 1,629 trades